Point72 Asset Management’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
NCNMGF
MBAM
Point72 Asset Management's XGN Position: Q3 2026 in Review
Point72 Asset Management opened a new position in Exagen (XGN) in Q3 2026: 16,267 shares worth $132K. The stake represents ﹤0.01% of the portfolio and ranks #3597 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in XGN as recently as Q1 2026.
Point72 Asset Management first reported a position in XGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.25M in Q4 2025. 78 funds tracked by Wall St. Rank hold XGN as of Q3 2026.
- Point72 Asset Management held 16,267 shares of Exagen worth $132K as of Q3 2026.
- Exagen was a new Point72 Asset Management position in Q3 2026.
- Exagen made up ﹤0.01% of Point72 Asset Management's portfolio in Q3 2026, its #3597 holding.
- Point72 Asset Management first reported a position in Exagen in Q2 2025 and has held it in 4 quarters since.
- Point72 Asset Management's Exagen position peaked at $1.25M in Q4 2025.
- 78 funds tracked by Wall St. Rank held Exagen as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.